Aerobiotix

Ohio, United States Founded: 2013 • Age: 13 yrs
UV-based disinfection systems are supplied for hospitals and facilities.
Request Access

About Aerobiotix

Aerobiotix is a company based in United States founded in 2013 by David Kirschman.. Aerobiotix has raised $25 million across 1 funding round from investors including Vivo Capital and Asahi Kasei Ventures. Aerobiotix offers products and services including Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro. Aerobiotix operates in a competitive market with competitors including R-Zero, Crystal IS, Germitec, RayVio and UV Partners, among others.

  • Headquarter Ohio, United States
  • Founders David Kirschman
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aerobiotix, Llc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $25 M (USD)

    in 1 rounds

  • Latest Funding Round
    $25 M (USD), Series A

    May 06, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aerobiotix

Aerobiotix offers a comprehensive portfolio of products and services, including Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Reduces infection risk in operating rooms using UV and HEPA filtration.

Decontaminates air by removing bioaerosols and surgical smoke.

Provides continuous air purification for healthcare environments.

Manages air quality to minimize microbial contamination.

People of Aerobiotix
Headcount 10-50
Employee Profiles 14
Employee Profiles
People
David Kirschman
President & CEO
People
Michael Schmitz
CFO
People
Paul Ciovacco
Vice President Of Global Sales
People
Heidi Bates
Area Sales Manager

Unlock access to complete

Funding Insights of Aerobiotix

Aerobiotix has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $25.0M
  • First Round

    (06 May 2021)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Series A - Aerobiotix Valuation Vivo Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aerobiotix

Aerobiotix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Vivo Capital and Asahi Kasei Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital and private equity firm
Founded Year Domain Location
Innovative global companies are supported through venture capital investments by Asahi Kasei Ventures.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aerobiotix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aerobiotix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aerobiotix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aerobiotix

Aerobiotix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as R-Zero, Crystal IS, Germitec, RayVio and UV Partners, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
UV-C disinfection devices for hospital infection control are developed.
domain founded_year HQ Location
Ultraviolet light-emitting diodes are provided using aluminum nitride technology.
domain founded_year HQ Location
UV-C disinfection systems for ultrasound probes are provided.
domain founded_year HQ Location
Provides educational content on online slots and gaming strategies.
domain founded_year HQ Location
UV-based air sterilization devices are supplied for healthcare settings.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aerobiotix

Frequently Asked Questions about Aerobiotix

When was Aerobiotix founded?

Aerobiotix was founded in 2013 and raised its 1st funding round 8 years after it was founded.

Where is Aerobiotix located?

Aerobiotix is headquartered in United States. It is registered at Ohio, United States.

Is Aerobiotix a funded company?

Aerobiotix is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series A of $25M, raised on May 06, 2021.

What does Aerobiotix do?

Provider of UV-based disinfection systems for hospitals and other establishments. The products in Healthcare include Illuvia (air treatment systems), GermZone (upper room UV air Germicidal Systems), and GermVac (Negative pressure germicidal system). The Homecare product contains physician-designed laboratory-proven technology- Aerocure. The HVAC product is the Ultra V 250UV. The first product of the company was Tower One (T1) designed for air purification and disinfection system.

Who are the top competitors of Aerobiotix?

Aerobiotix's top competitors include R-Zero, Germitec and AquiSense.

What products or services does Aerobiotix offer?

Aerobiotix offers Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro.

Who are Aerobiotix's investors?

Aerobiotix has 2 investors. Key investors include Vivo Capital, and Asahi Kasei Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available